Endoscope Reprocessing Market - Growth, Trends, Covid-19 Impact, Forecasts (2022 - 2027)

Endoscope Reprocessing Market - Growth, Trends, Covid-19 Impact, Forecasts (2022 - 2027)

The endoscope reprocessing market is poised to grow at a CAGR of 7.8% during the forecasted period.

There is a high risk of transmission of the COVID-19 virus during endoscopy surgery. Various countries have penned down several guidelines to keep all non-emergent surgeries on halt. In September 2020, the Department of Medicine A, University Medicine Greifswald, Germany, conducted a survey in 48 countries and discovered that during the COVID-19 pandemic, all centers (99%) reduced their endoscopy volumes. A majority of these centers (85%) reported a greater than 50% reduction in endoscopy volumes.

According to the study published in Zeitschrift für Gastroenterologie, titled ‘Work satisfaction and risk of burnout for endoscopy staff in Germany: Results of a nationwide survey’ in January 2021, because qualified workers are in short supply in many places, the endoscopic staff is increasingly at danger of suffering burnout symptoms. Frequently mentioned critical aspects such as a lack of development opportunities and non-performance-based compensation should be taken seriously, and measures should be developed to avoid endangering endoscopy care in the long run. Such burnouts in the endoscopy staff will therefore lead to a lack of skilled professionals in endoscopy, hindering the market growth.

Furthermore, according to the study published in Frontiers in Medicine, titled ‘Use of Artificial Intelligence to Improve the Quality Control of Gastrointestinal Endoscopy’ in July 2021, as the quantity and variety of endoscopies have increased, issues such as a shortage of qualified endoscopists and disparities in the professional competency of doctors with varying degrees of experience have grown more apparent. Such a rise in the shortage of endoscopists will lead to the lack of availability of skilled professionals for endoscopic diagnosis, hampering the market growth.

The major factors driving the growth of the endoscope reprocessing market include the rising cases of endoscopy-related infections, growing hospital investments in endoscopy instruments, and the rising number of diseases that require endoscopy procedures. Increased usage of endoscopic devices has been observed in disease diagnosis and treatment. The growing burden of respiratory diseases, such as lung cancer, chronic obstructive pulmonary disorders, and others, is propelling the growth of the market over the forecast period. For instance, the World Health Organization’s article titled ‘’Chronic Obstructive Pulmonary Disease (COPD)’’, updated in January 2022, reported that Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. It has led to nearly 3.23 million deaths in 2021 and out of these over 80% of deaths occurred in the low- and middle-income countries (LMIC). Such a high burden of Chronic Obstructive Pulmonary Disease generates the need for proper treatment of the disease, and since endoscopes are employed in lung volume reduction surgery for the treatment of it, it is expected to propel the growth of the market.

Additionally, the rising number of cancer cases is also augmenting the growth of the market. For instance, Globocan Statistics 2020 reported that there are an estimated 19.3 million cases of cancer among all age groups around the globe in 2020, and it is estimated to reach 30.2 million by 2040. The same source also reported that out of these cases, 1.15 million cases are of colon cancer, which is expected to reach 1.92 million by 2040. Such a rapidly rising burden of different types of cancers, in which the endoscopes are largely used for diagnostic purposes, is boosting the growth of the endoscope reprocessing over time.

Furthermore, rising demand for surgeries with faster recovery, fewer post-surgery infections, less pain, reduced scarring, better control on bleeding, and increased accuracy are anticipated to boost the demand for various endoscopy devices. Major players in the market are focusing on the approval of new products to expand their product portfolio. For instance, in April 2021, Advanced Sterilization Products received United States Food and Drug Administration’s approval for the ASP AEROFLEX Automatic Endoscope Reprocessor. Thus, the rising number of endoscopy reprocessing devices in the market will likely lead to the high growth of the market.

However, dearth of skilled professionals to carry out endoscopic procedures and the concerns regarding the safety of reprocessed instruments are the factors expected to hinder market growth.

Key Market TrendsAutomated Endoscope Reprocessors Segment is Expected to Register Good Growth Over the Forecast Period

The increasing product launches and approvals, given the added features of automated endoscope reprocessors, are expected to drive the studied segment over the forecast period. Similarly, in June 2022, Getinge launched an updated version of the ED-Flow automated endoscope reprocessors. ED-Flow efficiently performs leak testing, cleaning, and high-level disinfection of flexible endoscopes, delivering effective, reliable results. New process indicator lights have been added to allow easy visibility of the process status from across the room, which creates improved department workflow leading to higher productivity. Hence, such innovative product launches would improve efficiency and will fuel market growth.

Furthermore, in October 2020, Olympus Corporation launched its OER-Elite next-generation automated endoscope reprocessor (AER) in the market. The OER-Elite simultaneously cleans and disinfects up to two endoscopes in 28 minutes. High-level disinfection is accomplished using Acecide-C, a peracetic acid-based disinfectant. The system also offers a cleaning cycle, using a combination of EndoQuick alkaline detergent and ultrasonic cleaning. Such improved technologies are expected to increase market growth.

Additionally, in May 2021, the United States Food and Drug Administration (FDA) granted 510(k) clearance for Advanced Sterilization’s ASP Aeroflex, a device that automatically cleans and sterilizes endoscopes. The Advanced Sterilization device can automatically clean and disinfect flexible endoscopes from multiple manufacturers in 22 minutes, eliminating the need to use manual test strips to measure the disinfectant’s concentration. Hence, such approvals are likely to increase market growth. Thus, owing to the above-mentioned factors, the studied market is expected to witness significant growth during the forecast period.

North America is Expected to Hold Largest Market Share over the Forecast Period

North America holds the majority of the share and in the North American region, the United States holds the major share. The rising number of disorders and the increasing launches and acquisitions by key market players in the region are the major drivers for the growth of the studied market. Increasing cases of cancer are expected to fuel market growth.

According to the estimates of Canada.ca (Government of Canada) around 26,300 Canadians were diagnosed with colorectal cancer in 2019 (14,600 males and 11,700 females) and 9,500 (5,200 males and 4,400 females) Canadians died from the disease. Increasing colorectal cancer would require a higher diagnostic rate, which will fuel the demand for endoscopy and hence will increase the growth rate of the studied market.

Additionally, the increasing number of product approvals and high concentration of major players in the region is expected to boost the market. For instance, in January 2020, PENTAX Medical launched DEC HD Duodenoscope, an advanced, high-definition duodenoscope that features multiple disposable components, including the sterile distal cap and elevator lever, for unit reprocessing in the United States. Similarly, in November 2020, PENTAX Medical launched its DEC HD Duodenoscope, which is an advanced, high-definition duodenoscope that features multiple disposable components, including the sterile distal cap and elevator lever, for unit reprocessing. The DEC HD Duodenoscope is designed to provide physicians with a solution aligned with recent FDA guidance on reducing endoscope reprocessing and delivering a tangible "Triple Aim" 1 value. The acquisition is another factor in the market growth. Hence, all the above-mentioned factors are expected to augment the growth of the North American market over the forecast period.

Competitive Landscape

The market studied involves both multinational and local companies owing to a large number of devices and consumables being used in the reprocessing process. Some of the market players are Advanced Sterilization Products (Johnson & Johnson Company), Cantel Medical, Custom Ultrasonics, Ecolab Inc, Endo-Technik W. Griesat, Getinge AB, Metrex Research, LLC., Olympus Corporation, STERIS plc., and Wassenburg Medical (A Member of Hoya).

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.